Guardado en:
Detalles Bibliográficos
Autores principales: Fu, Ziwei, Wang, Tongchao, Zhang, Chenyang, Qi, Tianyu, Chen, Yanyan, Yang, Ju, Yang, Hua, Yan, Bing, Gong, Baoming, Lu, Weiqiao, Luo, Sushan, Liu, Ying, Sun, Lei, Jiang, Hao, Chen, Bo, Zhang, Zhao, Liu, Xiuping, Wang, Yuxiang
Formato: Artículo científico
Lenguaje:en
Publicado: Nature communications 2026
Materias:
Acceso en línea:https://pubmed.ncbi.nlm.nih.gov/41957353/
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1868266061992820738
author Fu, Ziwei
Wang, Tongchao
Zhang, Chenyang
Qi, Tianyu
Chen, Yanyan
Yang, Ju
Yang, Hua
Yan, Bing
Gong, Baoming
Lu, Weiqiao
Luo, Sushan
Liu, Ying
Sun, Lei
Jiang, Hao
Chen, Bo
Zhang, Zhao
Liu, Xiuping
Wang, Yuxiang
author_facet Fu, Ziwei
Wang, Tongchao
Zhang, Chenyang
Qi, Tianyu
Chen, Yanyan
Yang, Ju
Yang, Hua
Yan, Bing
Gong, Baoming
Lu, Weiqiao
Luo, Sushan
Liu, Ying
Sun, Lei
Jiang, Hao
Chen, Bo
Zhang, Zhao
Liu, Xiuping
Wang, Yuxiang
Fu, Ziwei
Wang, Tongchao
Zhang, Chenyang
Qi, Tianyu
Chen, Yanyan
Yang, Ju
Yang, Hua
Yan, Bing
Gong, Baoming
Lu, Weiqiao
Luo, Sushan
Liu, Ying
Sun, Lei
Jiang, Hao
Chen, Bo
Zhang, Zhao
Liu, Xiuping
Wang, Yuxiang
collection PubMed - marine biology
contents Gmppb-mutant mice exhibit dystroglycanopathy symptoms that are rescued with GSK3β inhibition or AAV-mediated GMPPB gene replacement. Fu, Ziwei Wang, Tongchao Zhang, Chenyang Qi, Tianyu Chen, Yanyan Yang, Ju Yang, Hua Yan, Bing Gong, Baoming Lu, Weiqiao Luo, Sushan Liu, Ying Sun, Lei Jiang, Hao Chen, Bo Zhang, Zhao Liu, Xiuping Wang, Yuxiang Animals Female Mice Male Dystroglycans Nucleotidyltransferases Glycogen Synthase Kinase 3 beta Mice, Knockout Mutation Muscle, Skeletal Wnt Signaling Pathway Glycosylation Disease Models, Animal Muscular Dystrophies Mutations in GDP-mannose pyrophosphorylase B (GMPPB) cause dystroglycanopathy, a rare neuromuscular disorder characterized by α-dystroglycan hypoglycosylation, yet the pathogenic mechanisms and therapeutic options remain poorly defined. To dissect the molecular basis of dystroglycanopathy, we generate Gmppb knockout and knock-in (P32L and R287Q) mice. We show that homozygous Gmppb knockout and P32L mutant mice (both male and female) display embryonic lethality, while heterozygous Gmppb-P32L (Gmppb) mice (both male and female) develop progressive muscular dystrophy accompanied by Purkinje cell loss, peripheral demyelination, and impaired nerve conduction. Integrated biochemical, transcriptomic, metabolomic and glycoproteomic analyses reveal widespread protein hypoglycosylation, metabolic dysregulation and suppressed Wnt/β-catenin signaling, resulting in defective differentiation and regeneration of muscle stem cells. Pharmacological activation of Wnt signaling with CHIR-99021 restores myogenic capacity and improves regeneration after injury. Furthermore, AAV-mediated GMPPB gene replacement reinstates α-dystroglycan glycosylation, normalizes GDP-mannose levels, and rescues motor and electrophysiological defects. Collectively, our findings establish Gmppb mice as a faithful model of GMPPB-associated dystroglycanopathy and demonstrate that Wnt pathway activation and AAV-based gene therapy represent promising strategies for treating glycosylation-defective muscular dystrophies.
format Artículo científico
id pubmed_41957353
institution PubMed
language en
publishDate 2026
publisher Nature communications
record_format pubmed
spellingShingle Gmppb-mutant mice exhibit dystroglycanopathy symptoms that are rescued with GSK3β inhibition or AAV-mediated GMPPB gene replacement.
Fu, Ziwei
Wang, Tongchao
Zhang, Chenyang
Qi, Tianyu
Chen, Yanyan
Yang, Ju
Yang, Hua
Yan, Bing
Gong, Baoming
Lu, Weiqiao
Luo, Sushan
Liu, Ying
Sun, Lei
Jiang, Hao
Chen, Bo
Zhang, Zhao
Liu, Xiuping
Wang, Yuxiang
Animals
Female
Mice
Male
Dystroglycans
Nucleotidyltransferases
Glycogen Synthase Kinase 3 beta
Mice, Knockout
Mutation
Muscle, Skeletal
Wnt Signaling Pathway
Glycosylation
Disease Models, Animal
Muscular Dystrophies
Gmppb-mutant mice exhibit dystroglycanopathy symptoms that are rescued with GSK3β inhibition or AAV-mediated GMPPB gene replacement. Fu, Ziwei Wang, Tongchao Zhang, Chenyang Qi, Tianyu Chen, Yanyan Yang, Ju Yang, Hua Yan, Bing Gong, Baoming Lu, Weiqiao Luo, Sushan Liu, Ying Sun, Lei Jiang, Hao Chen, Bo Zhang, Zhao Liu, Xiuping Wang, Yuxiang Animals Female Mice Male Dystroglycans Nucleotidyltransferases Glycogen Synthase Kinase 3 beta Mice, Knockout Mutation Muscle, Skeletal Wnt Signaling Pathway Glycosylation Disease Models, Animal Muscular Dystrophies Mutations in GDP-mannose pyrophosphorylase B (GMPPB) cause dystroglycanopathy, a rare neuromuscular disorder characterized by α-dystroglycan hypoglycosylation, yet the pathogenic mechanisms and therapeutic options remain poorly defined. To dissect the molecular basis of dystroglycanopathy, we generate Gmppb knockout and knock-in (P32L and R287Q) mice. We show that homozygous Gmppb knockout and P32L mutant mice (both male and female) display embryonic lethality, while heterozygous Gmppb-P32L (Gmppb) mice (both male and female) develop progressive muscular dystrophy accompanied by Purkinje cell loss, peripheral demyelination, and impaired nerve conduction. Integrated biochemical, transcriptomic, metabolomic and glycoproteomic analyses reveal widespread protein hypoglycosylation, metabolic dysregulation and suppressed Wnt/β-catenin signaling, resulting in defective differentiation and regeneration of muscle stem cells. Pharmacological activation of Wnt signaling with CHIR-99021 restores myogenic capacity and improves regeneration after injury. Furthermore, AAV-mediated GMPPB gene replacement reinstates α-dystroglycan glycosylation, normalizes GDP-mannose levels, and rescues motor and electrophysiological defects. Collectively, our findings establish Gmppb mice as a faithful model of GMPPB-associated dystroglycanopathy and demonstrate that Wnt pathway activation and AAV-based gene therapy represent promising strategies for treating glycosylation-defective muscular dystrophies.
title Gmppb-mutant mice exhibit dystroglycanopathy symptoms that are rescued with GSK3β inhibition or AAV-mediated GMPPB gene replacement.
topic Animals
Female
Mice
Male
Dystroglycans
Nucleotidyltransferases
Glycogen Synthase Kinase 3 beta
Mice, Knockout
Mutation
Muscle, Skeletal
Wnt Signaling Pathway
Glycosylation
Disease Models, Animal
Muscular Dystrophies
url https://pubmed.ncbi.nlm.nih.gov/41957353/